revenue for Q3/2017 of 95.0 million baht compared with Q3/2016 of 92.8 million baht, increased 2.2 million baht or 2.4 percent. The company reported profit for Q3/2017 of 4.7 million baht compared with
from payments. While cash and cash equivalents increased by 71.28 million baht. In terms of non-current assets, an increase of 96.92 million baht, mainly due to an increase in the right to use assets of
- Phatthanakan) was inaugurated where the patients accepted replacement therapy with dialysis machines increased steadily to fully capacity. In the 1 st quarter 2017, the subsidiary purchases more dialysis
Million Baht or 17.20% because of, the delay in customer purchases and current economic conditions. Cost of Sales For financial statement in Quarter 1/2018, the cost of sales was recorded at 12.08 Million
decreased 18% to THB 409m in Q2 2019 from THB 500m in Q2 2018. Net Profit increased 98% to THB 536m in Q219 from THB 270m in Q218, due exchange gain of 103m in Q219 vs exchange loss of 236m in Q218. Quarter
from the Company ordered goods in last quarter of 2018 and paid advance payment for purchases of goods followed by supplier’s condition. Deferred tax assets was increased by Baht 19.07 million due to
training, resulting in an increase in operating expenses in many items. As a result, selling and administrative expenses increased. Furthermore, the Company recorded the impairment loss on financial assets
5.2 billion for the first quarter of 2018 from THB 5.2 billion for the first quarter 2017. Sales Revenue in USD terms increased 10% to USD 165m for Q1 2018 from USD 149m in Q1 2017. Operating Profits
measures which increased the conditions in loan provision for real estate purchases. 3.4 Sales and service income from concrete products manufacturing and others in the second quarter of 2019, has increased
increased steadily to fully capacity. In the 1st quarter , the subsidiary purchases more dialysis machines to accommodate more patients. In addition, on February , , this subsidiary inaugurated a dialysis